2,000
Participants
Start Date
October 31, 2024
Primary Completion Date
April 30, 2025
Study Completion Date
October 30, 2025
Level of blood sugar control (e.g., hemoglobin A1C), severity of infection, blood supply status, and other complications (e.g., peripheral neuropathy)
Level of blood sugar control (e.g., hemoglobin A1C), severity of infection, blood supply status, and other complications (e.g., peripheral neuropathy)
National Clinical Medical Research Center for Metabolic Diseases (Shanghai), Shanghai
Shanghai Jiao Tong University School of Medicine
OTHER